| Journal Article |
File Downloads |
Abstract Views |
| Last month |
3 months |
12 months |
Total |
Last month |
3 months |
12 months |
Total |
| A Pilot Test of Using the Veil of Ignorance Approach to Estimate a Social Welfare Function for Income |
1 |
1 |
4 |
15 |
3 |
3 |
19 |
134 |
| A comparison of individual and social time trade-off values for health states in the general population |
0 |
0 |
2 |
8 |
1 |
3 |
6 |
21 |
| A comparison of patient and social tariff values derived from the time trade-off method |
0 |
0 |
0 |
0 |
2 |
3 |
21 |
68 |
| A note on prevention versus cure |
0 |
0 |
3 |
8 |
1 |
1 |
15 |
31 |
| A note on the depreciation of the societal perspective in economic evaluation of health care |
1 |
1 |
1 |
5 |
2 |
2 |
8 |
20 |
| A note on the effect of unemployment on mortality |
1 |
3 |
20 |
83 |
2 |
6 |
50 |
187 |
| A note on the estimation of the equity-efficiency trade-off for QALYs |
1 |
2 |
4 |
31 |
2 |
3 |
12 |
71 |
| A note on validating Wagstaff and van Doorslaer's health measure in the analysis of inequalities in health |
1 |
4 |
14 |
60 |
6 |
13 |
43 |
156 |
| Absolute Income, Relative Income, Income Inequality, and Mortality |
0 |
2 |
2 |
2 |
1 |
5 |
5 |
5 |
| Advantages of Using the Net-Benefit Approach for Analysing Uncertainty in Economic Evaluation Studies |
0 |
2 |
15 |
21 |
5 |
15 |
232 |
322 |
| An Experimental Comparison of Dichotomous Choice Contingent Valuation Questions and Real Purchase Decisions |
2 |
3 |
13 |
40 |
5 |
6 |
23 |
119 |
| An experimental test of question framing in health state utility assessment |
1 |
1 |
1 |
5 |
2 |
4 |
12 |
41 |
| Assessment of the Relationship Between Measures of Disease Severity, Quality of Life, and Willingness to Pay in Asthma |
1 |
1 |
6 |
8 |
4 |
8 |
31 |
54 |
| Calibrating Hypothetical Willingness to Pay Responses |
0 |
1 |
5 |
32 |
1 |
2 |
12 |
114 |
| Characterizing QALYs by Risk Neutrality |
0 |
0 |
2 |
29 |
1 |
4 |
25 |
138 |
| Communication: Content or relationship? |
1 |
1 |
12 |
17 |
13 |
33 |
130 |
187 |
| Confidence interval estimation tasks and the economics of overconfidence |
2 |
2 |
6 |
46 |
3 |
7 |
34 |
175 |
| Consumption and Health |
0 |
2 |
14 |
55 |
1 |
14 |
72 |
199 |
| Contingent valuation with an open-ended follow-up question: a test of scope effects |
0 |
0 |
0 |
1 |
1 |
4 |
35 |
87 |
| Cost-effectiveness analysis of hypertension treatment -- A review of methodological issues |
0 |
1 |
19 |
54 |
3 |
7 |
62 |
157 |
| Cost-utility analysis and varying preferences for health |
0 |
1 |
3 |
5 |
1 |
2 |
11 |
16 |
| Cost-utility analysis from a societal perspective |
0 |
1 |
7 |
16 |
1 |
2 |
22 |
41 |
| Crowding Out in Blood Donation: Was Titmuss Right? |
0 |
6 |
44 |
59 |
22 |
53 |
217 |
297 |
| Do Life-Saving Regulations Save Lives? |
1 |
1 |
3 |
37 |
2 |
3 |
15 |
119 |
| Economic evaluation in health care: Is there a role for cost-benefit analysis? |
11 |
36 |
160 |
218 |
19 |
93 |
425 |
524 |
| Economic evaluation of lipid lowering -- A feasibility test of the contingent valuation approach |
1 |
1 |
1 |
1 |
2 |
2 |
12 |
21 |
| Economic evaluation of osteoporosis prevention |
0 |
1 |
4 |
14 |
2 |
4 |
16 |
40 |
| Editorial: Some reflections on cost-effectiveness analysis |
0 |
0 |
0 |
0 |
2 |
4 |
10 |
33 |
| Effects of user charges on the use of prescription medicines in different socio-economic groups |
0 |
0 |
3 |
8 |
1 |
1 |
6 |
18 |
| Eliciting Willingness to Pay Without Bias: Evidence from a Field Experiment |
1 |
7 |
27 |
55 |
4 |
16 |
73 |
162 |
| Eliciting Willingness to Pay without Bias using Follow-up Certainty Statements: Comparisons between Probably/Definitely and a 10-point Certainty Scale |
3 |
3 |
3 |
3 |
8 |
11 |
11 |
11 |
| Experimental Results on Expressed Certainty and Hypothetical Bias in Contingent Valuation |
0 |
0 |
0 |
0 |
2 |
11 |
23 |
23 |
| Gender differences in deception |
6 |
7 |
28 |
41 |
13 |
23 |
77 |
111 |
| Genetic Variation in Preferences for Giving and Risk Taking |
8 |
12 |
14 |
14 |
14 |
32 |
41 |
41 |
| Health-related quality of life by disease and socio-economic group in the general population in Sweden |
0 |
0 |
2 |
13 |
1 |
1 |
8 |
34 |
| Heritability of Overconfidence |
2 |
4 |
8 |
8 |
7 |
23 |
33 |
33 |
| Hypothetical versus Real Willingness to Pay: Some Experimental Results |
0 |
1 |
6 |
24 |
1 |
3 |
12 |
74 |
| Hypothetical versus real payments in Vickrey auctions |
0 |
2 |
6 |
20 |
1 |
3 |
10 |
65 |
| Hypothetical versus real willingness to pay in the health care sector: results from a field experiment |
2 |
4 |
18 |
90 |
4 |
6 |
33 |
201 |
| Income-related inequality in life-years and quality-adjusted life-years |
0 |
0 |
0 |
11 |
2 |
3 |
8 |
57 |
| Incorporating quality of life changes into economic evaluations of health care: an overview |
0 |
0 |
1 |
1 |
2 |
2 |
6 |
14 |
| Increasing socio-economic inequalities in life expectancy and QALYs in Sweden 1980-1997 |
1 |
4 |
16 |
37 |
5 |
19 |
84 |
255 |
| Is Altruism Paternalistic? |
3 |
5 |
17 |
26 |
5 |
10 |
39 |
111 |
| Is There a Hold-up Problem? |
1 |
2 |
10 |
50 |
5 |
10 |
46 |
207 |
| Is generosity involuntary? |
1 |
2 |
11 |
48 |
4 |
9 |
25 |
103 |
| Is the valuation of a QALY gained independent of age? Some empirical evidence |
1 |
1 |
8 |
55 |
5 |
8 |
42 |
167 |
| Non-reciprocal altruism in dictator games |
0 |
1 |
8 |
64 |
2 |
5 |
27 |
183 |
| On aggregating QALYs: a comment on Dolan |
0 |
0 |
4 |
12 |
1 |
1 |
6 |
39 |
| On the Value of Changes in Life Expectancy: Blips versus Parametric Changes |
0 |
1 |
8 |
37 |
2 |
4 |
27 |
149 |
| On the decision rules of cost-effectiveness analysis |
2 |
7 |
62 |
196 |
8 |
23 |
175 |
469 |
| On the estimation of cost-effectiveness ratios |
0 |
0 |
1 |
3 |
1 |
1 |
3 |
12 |
| Patients' willingness to pay for autologous blood donation |
1 |
1 |
1 |
7 |
2 |
2 |
9 |
32 |
| Paying Respect |
0 |
0 |
0 |
0 |
3 |
12 |
74 |
180 |
| Price Indices of Drugs and the Switching to New Drugs: Two Empirical Examples |
0 |
1 |
6 |
6 |
7 |
12 |
46 |
62 |
| Pride and Prejudice: The Human Side of Incentive Theory |
4 |
12 |
55 |
58 |
6 |
30 |
192 |
215 |
| Promises, Threats and Fairness |
4 |
7 |
18 |
57 |
5 |
13 |
37 |
160 |
| Qalys: A comment |
0 |
0 |
1 |
11 |
1 |
2 |
4 |
38 |
| Quality of life and the WTP for an increased life expectancy at an advanced age |
0 |
0 |
3 |
35 |
1 |
2 |
16 |
100 |
| Quality-adjusted life-years versus healthy-years equivalents -- A comment |
0 |
0 |
5 |
26 |
2 |
3 |
17 |
96 |
| Saving Lives in the Present versus Saving Lives in the Future--Is There a Framing Effect? |
0 |
0 |
2 |
14 |
1 |
2 |
11 |
79 |
| Should we aggregate relative or absolute changes in QALYs? |
0 |
1 |
5 |
13 |
3 |
4 |
9 |
24 |
| Some Further Experimental Results on Hypothetical versus Real Willingness to Pay |
0 |
1 |
1 |
9 |
1 |
3 |
5 |
40 |
| Standard gamble, time trade-off and rating scale: Experimental results on the ranking properties of QALYs |
1 |
8 |
20 |
100 |
3 |
16 |
94 |
335 |
| Stated Preferences, Real Behaviour and Anchoring: Some Empirical Evidence |
0 |
0 |
6 |
15 |
2 |
3 |
29 |
60 |
| Sunk costs and fairness in incomplete information bargaining |
1 |
3 |
5 |
30 |
2 |
6 |
15 |
70 |
| The Effect of Changes in Treatment Patterns on Drug Expenditure |
1 |
2 |
3 |
4 |
2 |
6 |
27 |
43 |
| The Value of Life Extension and the Marginal Rate of Time Preference: A Pilot Study |
1 |
1 |
3 |
35 |
2 |
3 |
29 |
163 |
| The Value of Private Safety versus the Value of Public Safety |
0 |
0 |
0 |
1 |
2 |
6 |
23 |
147 |
| The authors reply |
0 |
0 |
0 |
0 |
1 |
1 |
4 |
7 |
| The aversion to lying |
0 |
0 |
0 |
0 |
4 |
4 |
4 |
4 |
| The cost-effectiveness of a cardiovascular risk reduction program in general practice |
0 |
0 |
5 |
18 |
2 |
2 |
14 |
46 |
| The cost-effectiveness of the switch towards more expensive antihypertensive drugs |
0 |
3 |
6 |
9 |
2 |
6 |
23 |
35 |
| The costs of treating hypertension -- an analysis of different cut-off points |
0 |
0 |
3 |
7 |
3 |
4 |
10 |
30 |
| The demand for health: results from new measures of health capital |
3 |
4 |
5 |
45 |
4 |
8 |
24 |
118 |
| The economics of ageing: on the attitude of Swedish people to the distribution of health care resources between the young and the old |
0 |
0 |
1 |
4 |
1 |
1 |
8 |
27 |
| The friction cost method: A comment |
0 |
0 |
3 |
51 |
1 |
2 |
13 |
176 |
| The relationship between happiness, health, and socio-economic factors: results based on Swedish microdata |
0 |
1 |
14 |
85 |
4 |
10 |
73 |
395 |
| The value of the change in health in Sweden 1980|81 to 1996|97 |
0 |
0 |
2 |
5 |
1 |
5 |
19 |
48 |
| The willingness to pay for health changes, the human-capital approach and the external costs |
0 |
1 |
5 |
20 |
1 |
2 |
12 |
44 |
| Time spent on waiting lists for medical care: an insurance approach |
1 |
3 |
6 |
32 |
2 |
4 |
14 |
70 |
| To Be, or Not to Be, That Is the Question: An Empirical Study of the WTP for an Increased Life Expectancy at an Advanced Age |
0 |
0 |
0 |
1 |
16 |
75 |
484 |
710 |
| Trust and Truth |
3 |
3 |
9 |
9 |
7 |
12 |
38 |
38 |
| Urge Incontinence: Quality of Life and Patients' Valuation of Symptom Reduction |
0 |
1 |
14 |
17 |
5 |
19 |
89 |
119 |
| Value for money? A contingent valuation study of the optimal size of the Swedish health care budget |
0 |
1 |
2 |
3 |
4 |
5 |
13 |
25 |
| Willingness to Pay for Lipid Lowering: A Health Production Function Approach |
0 |
0 |
0 |
0 |
3 |
5 |
13 |
132 |
| Willingness to pay for antihypertensive therapy -- further results |
0 |
2 |
10 |
26 |
1 |
6 |
28 |
94 |
| Willingness to pay for antihypertensive therapy -- results of a Swedish pilot study |
1 |
2 |
12 |
32 |
3 |
8 |
48 |
123 |
| Total Journal Articles |
77 |
195 |
857 |
2,471 |
318 |
835 |
3,958 |
10,001 |
LogEc is hosted by the
Swedish Business School at Örebro University.